Literature DB >> 20643228

Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas.

R L Correia1, S M Oba-Shinjo, M Uno, N Huang, S K N Marie.   

Abstract

Mitochondrial DNA (mtDNA) alterations and their clinical and pathological implications have been analyzed in several human malignancies. A marked decrease in mtDNA copy number along with the increase in malignancy was observed in diffusely infiltrating astrocytomas (24 WHO grade II, 18 grade III, and 78 grade IV or GBM) compared to non-neoplastic brain tissues, being mostly depleted in GBM. Although high relative gene expression levels of mtDNA replication regulators (mitochondrial polymerase catalytic subunit (POLG), transcription factors A (TFAM), B1 (TFB1M) and B2 (TFB2M)) were detected, it cannot successfully revert the mtDNA depletion observed in our samples. On the other hand, a strong correlation among the expression levels of mitochondrial transcription factors corroborates with the TFAM role in the direct control of TFB1M and TFB2M during initiation of mtDNA replication. POLG expression was related to decreased mtDNA copy number, and its overexpression associated with TFAM expression levels also have an impact on long-term survival among GBM patients, interpreted as a potential predictive factor for better prognosis.
Copyright © 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643228     DOI: 10.1016/j.mito.2010.07.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  26 in total

1.  High copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patients.

Authors:  Yanfang Zhang; Yiping Qu; Ke Gao; Qi Yang; Bingyin Shi; Peng Hou; Meiju Ji
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 2.  Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.

Authors:  Satish Srinivasan; Manti Guha; Anna Kashina; Narayan G Avadhani
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-01-16       Impact factor: 3.991

Review 3.  Mitochondrial pathways to cardiac recovery: TFAM.

Authors:  George H Kunkel; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 4.  The awakening of an advanced malignant cancer: an insult to the mitochondrial genome.

Authors:  Cody C Cook; Masahiro Higuchi
Journal:  Biochim Biophys Acta       Date:  2011-09-02

5.  Damaged mitochondrial DNA replication system and the development of diabetic retinopathy.

Authors:  Shikha Tewari; Julia M Santos; Renu A Kowluru
Journal:  Antioxid Redox Signal       Date:  2012-02-17       Impact factor: 8.401

6.  Screening feature genes of astrocytoma using a combined method of microarray gene expression profiling and bioinformatics analysis.

Authors:  Yong Cai; Xingming Zhong; Yiqi Wang; Jianguo Yang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.

Authors:  M Guha; S Srinivasan; G Ruthel; A K Kashina; R P Carstens; A Mendoza; C Khanna; T Van Winkle; N G Avadhani
Journal:  Oncogene       Date:  2013-11-04       Impact factor: 9.867

Review 8.  Metabolism and brain cancer.

Authors:  Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  Mitochondrial signaling: forwards, backwards, and in between.

Authors:  Sean P Whelan; Brian S Zuckerbraun
Journal:  Oxid Med Cell Longev       Date:  2013-05-29       Impact factor: 6.543

10.  Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines.

Authors:  Anelisa Ramão; Marcela Gimenez; Helen Julie Laure; Clarice Izumi; Rodrigo Cesar Dos Santos Vida; Sueli Oba-Shinjo; Suely Kazue Nagahashi Marie; Jose Cesar Rosa
Journal:  Proteome Sci       Date:  2012-09-03       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.